Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03457922 · ClinicalTrials.gov registry record

Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety

A clinical trial of Anxiety Disorders, sponsored by Stanford University.

Completed
Registry status
45
Enrollment target
1
Study location

NCT03457922 is a study of Anxiety Disorders that has completed, run by Stanford University. The registered enrollment target is 45 participants, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03457922, a study of Anxiety Disorders, has completed, sponsored by Stanford University.

COMPLETED
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

This study is examining the impact of a therapy group for all anxiety disorders provided by the Stanford Department of Psychiatry and Behavioral Sciences's Psychosocial Treatment Clinic on anxiety symptoms, impairment, and access to quality mental health care.

Conditions Studied

Study Locations (1)

California

  • Stanford University Department of Psychiatry & Behavioral Sciences - Palo Alto

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2018-02-05
Est. Completion 2019-10-06

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03457922

The ClinicalTrials.gov registry entry for NCT03457922 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT03457922 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03457922 about?

NCT03457922 is a clinical study titled "Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety". This study is examining the impact of a therapy group for all anxiety disorders provided by the Stanford Department of Psychiatry and Behavioral Sciences's Psychosocial Treatment Clinic on anxiety symptoms, impairment, and access to quality mental health care.

What is the current status of trial NCT03457922?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2018-02-05. Estimated completion is 2019-10-06.

What conditions does trial NCT03457922 study?

This clinical trial studies the following conditions: Anxiety Disorders.

Who is sponsoring clinical trial NCT03457922?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03457922 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.